• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Linkedin

Was once there myself! So glad to have left Merck. I do actually feel bad for many of these people that think the ctl job is real and has any relevant skills as it does not.
 












What is ashley madison? I do kinda feel bad as it is so sad that people waste twenty years and think merck experience has any value to real companies. Well it once did but hasn't in almost ten years. And all the dilution by the scheming merger ruined any reputation that was left.